Key result
Treatment with bivalirudin successfully resolved delayed-onset heparin-induced thrombocytopenia and cerebral venous sinus thrombosis in a patient with acute intracerebral hemorrhage.
Why the study?
HIT-induced cerebral venous sinus thrombosis is rare and carries high morbidity and mortality, creating a need to further characterize its etiology, presentation, treatment paradigms, and outcomes.
Case Report (n=1)
No
This case demonstrates that delayed-onset HIT with CVST can occur after brief exposure to prophylactic enoxaparin and can be successfully managed with direct thrombin inhibitors despite acute intracerebral hemorrhage.
Heparin-induced thrombocytopenia (HIT) is a prothrombotic state caused by autoantibodies against platelet factor 4 (PF4)-heparin complexes. Although HIT typically presents 5-10 days after the initiation of heparin, thrombosis and thrombocytopenia may occur up to several weeks following heparin withdrawal, so-called delayed-onset HIT. Although rare, there have been isolated reports of HIT-induced cerebral venous sinus thrombosis (CVST), which carry high rates of morbidity and mortality. There is a need to further characterize the etiology, clinical presentation, treatment paradigms, and outcomes of patients with HIT-induced CVST. Here, we present the case of a 57-year old female who presented to the emergency department with a headache and seizure 11 days following a right total knee arthroplasty for which she received 3 post-operative doses of enoxaparin. Work-up demonstrated acute intracerebral hemorrhage (ICH), CVST, and thrombocytopenia. Intravenous heparin resulted in rapidly deteriorating platelet count and subsequent serologic testing confirmed the diagnosis of HIT. Treatment with bivalirudin was initiated, the HIT resolved, and the patient was discharged home on hospital day 19 with long-term anticoagulation mediated by warfarin. At 3-month follow up, the patient had mild upper motor neuron pattern weakness and was living independently. This case depicts a rare case of delayed-onset HIT and CVST, highlights the importance of establishing a fluid treatment plan for managing HIT-induced CVST, and illustrates the importance of employing rapid anticoagulation despite acute ICH to achieve a desirable clinical outcome.
No takes yet. Share an insight, caveat, or question.
Bauman et al. (2021) conducted a case report in Delayed-onset heparin-induced thrombocytopenia with cerebral venous sinus thrombosis (n=1). Bivalirudin was evaluated. Treatment with bivalirudin successfully resolved delayed-onset heparin-induced thrombocytopenia and cerebral venous sinus thrombosis in a patient with acute intracerebral hemorrhage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: